Price Alert

Translational Development... (TDAC)

NASDAQ: TDAC · Real-Time Price · USD

10.32

0.00 (0.00%)

At close: Aug 15, 2025, 10:41 AM

Translational Development Acquisition Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	May 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-347.41K	-133.39K	-61.28K	-843	-843	n/a	-500	-602	-602	-1.7K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.48M	-8.04K	-61.28K	-843	-843	-483.85K	-500	-602	-602	-1.7K
Net Income	1.48M	-8.04K	-61.28K	-843	-843	-483.85K	-500	-602	-602	-1.7K
Selling & General & Admin	347.41K	133.39K	61.28K	843.00	843.00	483.85K	500.00	602.00	602.00	1.7K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	347.41K	133.39K	61.28K	843.00	843.00	483.85K	500.00	602.00	602.00	1.7K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	133.39K	61.28K	843.00	843.00	483.85K	500.00	602.00	602.00	1.7K
Income Tax Expense	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.05M	4.05M	4.05M	4.05M	4.05M	4.05M	4.07M	4.07M	4.07M	3.76M
Shares Outstanding (Diluted)	4.05M	4.05M	4.05M	4.05M	4.05M	4.05M	4.05M	4.05M	4.05M	3.75M
EPS (Basic)	0.37	-0.00	-0.02	-0.00	-0.00	-0.12	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	0.37	-0.00	-0.02	-0.00	-0.00	-0.12	-0.00	-0.00	-0.00	-0.00
EBITDA	-347.41K	-135.07K	-61.28K	n/a	n/a	-483.85K	-500	n/a	n/a	n/a
EBIT	n/a	-133.39K	-61.28K	-843	-843	-483.85K	-500	-602	-602	-1.7K
Depreciation & Amortization	n/a	-1.69K	n/a	843.00	843.00	n/a	n/a	602.00	602.00	1.7K